Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.
- DOI
- 10.1093/eurheartj/ehae225
- Published
- 2024 May 21
- Container
- European heart journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/eurheartj/ehae225,
title = {Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.},
author = {Lip GYH and Nikorowitsch J and Sehner S and Becher N and Bertaglia E and Blomstrom-Lundqvist C and Brandes A and Beuger V and Calvert M and Camm AJ and Chlouverakis G and Dan GA and Dichtl W and Diener HC and Fierenz A and Goette A and de Groot JR and Hermans A and Lubinski A and Marijon E and Merkely B and Mont L and Ozga AK and Rajappan K and Sarkozy A and Scherr D and Schnabel RB and Schotten U and Simantirakis E and Toennis T and Vardas P and Wichterle D and Zapf A and Kirchhof P},
year = {2024},
journal = {European heart journal},
doi = {10.1093/eurheartj/ehae225},
url = {https://doi.org/10.1093/eurheartj/ehae225}
}RIS
TY - JOUR TI - Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial. AU - Lip GYH AU - Nikorowitsch J AU - Sehner S AU - Becher N AU - Bertaglia E AU - Blomstrom-Lundqvist C AU - Brandes A AU - Beuger V AU - Calvert M AU - Camm AJ AU - Chlouverakis G AU - Dan GA AU - Dichtl W AU - Diener HC AU - Fierenz A AU - Goette A AU - de Groot JR AU - Hermans A AU - Lubinski A AU - Marijon E AU - Merkely B AU - Mont L AU - Ozga AK AU - Rajappan K AU - Sarkozy A AU - Scherr D AU - Schnabel RB AU - Schotten U AU - Simantirakis E AU - Toennis T AU - Vardas P AU - Wichterle D AU - Zapf A AU - Kirchhof P PY - 2024 JO - European heart journal DO - 10.1093/eurheartj/ehae225 UR - https://doi.org/10.1093/eurheartj/ehae225 ER -
APA
GYH, L., J, N., S, S., N, B., E, B., C, B., A, B., V, B., M, C., AJ, C., G, C., GA, D., W, D., HC, D., A, F., A, G., JR, D. G., A, H., A, L., E, M., B, M., L, M., AK, O., K, R., A, S., D, S., RB, S., U, S., E, S., T, T., P, V., D, W., A, Z., & P, K. (2024). Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.. European heart journal. https://doi.org/10.1093/eurheartj/ehae225
Source records
- pubmed · retrieved 2026-09-26T10:11:05.192Z